You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Subclinical Antibody-mediated rejection (ABMR)

Showing 1 - 25 of 9,819
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

ddcfDNA in Kidney Transplant Recipients

Recruiting
  • Kidney Transplant Rejection
  • AlloSeq cfDNA
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Aug 22, 2023

Antibody-mediated Rejection, Lung Transplant Rejection Trial (Extracorporeal Photopheresis)

Not yet recruiting
  • Antibody-mediated Rejection
  • Lung Transplant Rejection
  • Extracorporeal Photopheresis
  • (no location specified)
Oct 30, 2023

Kidney Transplant Rejection, Antibody-mediated Rejection, Kidney Transplant Failure Trial in Berlin (Kidney allograft biopsy

Active, not recruiting
  • Kidney Transplant Rejection
  • +2 more
  • Kidney allograft biopsy depending on donor-derived cell-free DNA levels
  • Berlin, Germany
    Charité-Universitätsmedizin
Jul 22, 2022

Incidence, Course and Outcome of ABMR in Kidney Transplantation

Not yet recruiting
  • Antibody-mediated Rejection
  • +2 more
  • Kidney Transplantation
  • +2 more
  • (no location specified)
Nov 17, 2021

Subclass of Donor-specific Antibody asRisk Factor of Antibody

Active, not recruiting
  • Antibody-mediated Rejection
    • Montpellier, Hérault, France
      CHU Lapeyronie
    Jan 18, 2023

    Antibody-mediated Rejection Trial in Vienna, Berlin (Felzartamab, Placebo)

    Recruiting
    • Antibody-mediated Rejection
    • Vienna, Austria
    • +1 more
    Aug 23, 2022

    Donor-Derived Cell-Free DNA With Tocilizumab Treatment for

    Active, not recruiting
    • Rejection Chronic Renal
    • Kidney Transplant Rejection
      • Los Angeles, California
        Cedars-Sinai Medical Center
      Jul 18, 2022

      Antibody-mediated Rejection, Allosensitization Trial in New York (Isatuximab, bone marrow biopsy)

      Not yet recruiting
      • Antibody-mediated Rejection
      • Allosensitization
      • New York, New York
        NYU Langone Health
      May 16, 2023

      Antibody-mediated Rejection, Kidney Tranplant Trial in Hangzhou (Daratumumab)

      Not yet recruiting
      • Antibody-mediated Rejection
      • Kidney Tranplant
      • Hangzhou, Zhejiang, China
        79# Qingchun Road
      Jun 21, 2023

      Antibody-mediated Rejection, Kidney Transplant; Complications, Transplant Glomerulopathy Trial in Los Angeles (Clazakizumab)

      Active, not recruiting
      • Antibody-mediated Rejection
      • +5 more
      • Los Angeles, California
        Norko Ammerman
      Mar 25, 2022

      ABO Blood Type Incompatible Kidney Transplantation, Antibody-mediated Rejection Trial in Seoul (5-gene classification model)

      Active, not recruiting
      • ABO Blood Type Incompatible Kidney Transplantation
      • Antibody-mediated Rejection
      • 5-gene classification model
      • Seoul, Korea, Republic of
        Seoul National University Hospital
      Oct 24, 2022

      Assess Burden of Disease Among Kidney Transplant Recipients With

      Recruiting
      • Antibody-mediated Rejection in Kidney Transplant
      • Chronic active AMR group
      • Non-Chronic active AMR group
      • Cardiff, United Kingdom
      • +4 more
      Aug 2, 2022

      Transplant Glomerulopathy Trial in Birmingham, Baltimore (Acthar gel)

      Terminated
      Has Results
      • Transplant Glomerulopathy
      • Acthar gel
      • Birmingham, Alabama
      • +1 more
      Oct 3, 2022

      Antibody Mediated Processes After Kidney Transplantation

      Recruiting
      • Kidney Transplant Failure and Rejection
      • AlloSure ddcfDNA assay
      • +3 more
      • Madison, Wisconsin
        University of Wisconsin - Madison
      Aug 16, 2022

      Antibody-mediated Rejection Trial in Tehran (Bortezomib)

      Recruiting
      • Antibody-mediated Rejection
      • Tehran, Iran, Islamic Republic of
        SBMU
      Jan 27, 2022

      Kidney Transplantation, Kidney Transplant Rejection Trial in Guangzhou

      Not yet recruiting
      • Kidney Transplantation
      • Kidney Transplant Rejection
        • Guangzhou, Guangdong, China
          The First Affiliated Hospital, Sun Yat-sen University
        Mar 19, 2023

        MuLtimodality EvaluatiOn of aNtibody mEdiated Damage in Heart

        Active, not recruiting
        • Transplant Failure
        • +2 more
        • Echocardiogram
        • +3 more
        • Majadahonda, Madrid, Spain
        • +2 more
        Jun 14, 2022

        Antibody-mediated Rejection, Cardiac Transplant Trial in Rochester (Daratumumab and hyaluronidase-fihj)

        Enrolling by invitation
        • Antibody-mediated Rejection
        • Cardiac Transplant
        • Daratumumab and hyaluronidase-fihj
        • Rochester, Minnesota
          Mayo Clinic Rochester
        Apr 11, 2022

        Antibody-mediated Rejection Trial in Gothenburg, Stockholm, Uppsala (Tocilizumab)

        Recruiting
        • Antibody-mediated Rejection
        • Gothenburg, Vastra Gotaland Regioin, Sweden
        • +2 more
        Feb 16, 2022

        Donor Specific B Cells and Antibody Mediated Rejection

        Terminated
        • Sensitized Kidney Transplant Recipients
          • Madison, Wisconsin
            University of Wisconsin Hospital and Clinics
          Dec 13, 2021

          Renal Transplant Rejection Trial in London (Fostamatinib)

          Recruiting
          • Renal Transplant Rejection
          • London, United Kingdom
            Imperial College NHS Healthcare Trust
          Oct 1, 2021

          Approach on Kidney Transplant Recipients With Antibody-Mediated

          Completed
          • Antibody-mediated Rejection
          • +2 more
            • Istanbul, Turkey
              Istanbul University
            May 16, 2021

            Lung Transplant Recipient, Donor Specific Antibodies, Antibody Mediated Rejection Trial in France (bronchoscopy.)

            Recruiting
            • Lung Transplant Recipient
            • +2 more
            • bronchoscopy.
            • Le Plessis Robinson, France
            • +4 more
            Feb 11, 2022

            Transplant Rejection Trial in Worldwide (BIVV020, Intravenous immunoglobulin (IVIg), Rituximab)

            Recruiting
            • Transplant Rejection
            • Westmead, New South Wales, Australia
            • +14 more
            Aug 2, 2022

            Kidney Transplantation Trial in Paris (Privigen (Human normal immunoglobulin G (IgG > 98 % purity)))

            Completed
            • Kidney Transplantation
            • Privigen (Human normal immunoglobulin G (IgG > 98 % purity))
            • Paris, Ile De France, France
              Service de Néphrologie et transplantation rénale - HU Saint-Loui
            Mar 8, 2021